Antonia Vogt graduated from Mandoulides School in 2015 and in 2020 she completed her studies in the field of Medicine and Science, earning the highest distinction in the UK.
She obtained a degree in Cellular and Molecular Biology from the University of Stirling in Scotland. At the same time, she was selected as an assistant professor for teaching and research against cancer. In 2018 she worked at the Institute Curie in France, participating in cancer research, and in 2019 she was selected to study and represent her university at the University of Illinois Champaign Urbana, USA, on a full scholarship, where she continued research on Glioblastoma.
In 2020, she began her PhD in surgery at the University of Cambridge, where she is currently studying on a full scholarship and as a scholar of the Onassis Foundation, while at the same time, she was selected as an assistant professor for teaching. She has taken on leadership roles in several prestigious medical companies and founded the Cambridge University Society of Robotic Surgery in 2021, of which she is also president.
At the same time, she is president of the Cambridge Neurological Society, while since 2020 she has been vice president of the MCR committee of her College at the University of Cambridge and ambassador of the College, focusing on supporting students through fundraising for scholarships. The young scientist has successfully completed an impressive academic journey, marked by numerous significant distinctions.
“I felt very happy and very grateful,” says Antonia Vogt, explaining that, with her ranking at the top of the Forbes 30 Under 30 list, “it gives me the opportunity to inspire other young people and motivate them not to be intimidated by the obstacles that appear in their way, because the one who will manage to keep the vision and the dream alive inside him or her, is sure to conquer it.”
Additionally, her brother, Kimon-Aristotle Vogt, also a student of Mandoulides School, has achieved significant milestones, beginning with his medal-winning performances at the National Mathematical Olympiads in Greece. On scholarships, he studied electrical engineering in the United States, where he then worked at Carnegie Mellon University as a Research Associate, developing AI algorithms to detect malfunctions via EEG and securing international patents. Along with graduates from leading universities such as MIT and Yale Medical School, he founded his own company, Sporo Health, which develops AI solutions that address key health challenges.
It is important, as he stresses, for young people to know that “life is hard, but they must find what they love and keep trying. If they manage to take it one step at a time and work hard day after day, the best days will come. Entrepreneurship is something most needed in Greece, and I personally didn’t know much about it until I went to Harvard. I encourage you to come up with ideas and pursue innovation. ”
Finally, Dimitris Delemisis (graduate of 2014) together with Dimitris Alexiadis and Giorgos Fotiadis created mbb.ai. This is the first platform worldwide that utilizes Artificial Intelligence (AI) to offer a realistic and interactive interview simulation experience, as well as personalized points of improvement. The platform has already been embraced by students from leading universities such as Harvard and MIT, as well as professionals such as Amazon and & Goldman Sachs. The mbb.ai team has many years of experience in the field of technology.
Dimitris Delemisis is a computer engineer and technology consultant for Ernst & Young Ireland. Specializing in Generative AI, he has advised public and private organizations in the UK and Europe, shaping their AI strategy.
We are very proud of our graduates and wish them well in all their projects!
